Postconization Surveillance of Cervical Adenocarcinoma in Situ: A Prospective Trial

John O. Schorge, Jayanthi S. Lea, Raheela Ashfaq

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

OBJECTIVE: To conduct a surveillance trial after conization to prospectively determine the outcome of conservative management of adenocarcinoma in situ (AIS). STUDY DESIGN: Women diagnosed with AIS were prospectively enrolled from September 2000 to September 2001. Eligibility criteria included patient age younger than 40 years, prior conization with negative margins and the desire to preserve fertility. Each cone biopsy specimen was secondarily reviewed. Postconization surveillance consisted of a liquid-based Pap test and endocervical curettage (ECC) every 4 months. Follow-up ended in September 2002. RESULTS: Ten women with a median age of 32 years (range, 26-37) were enrolled. Six were nulliparous and 2 primiparous. Seven patients were clinically free of disease after a median of 21 months (range, 5-24), 2 were lost to follow-up, and 1 was excluded when AIS could not be confirmed on the original specimen. Twenty-eight Pap smears and 18 ECCs were performed, but no additional surgical procedures were required due to abnormal cytopathology. CONCLUSION: This prospective trial on postconization surveillance demonstrated the safety of conservative management for AIS patients desiring to preserve fertility.

Original languageEnglish (US)
Pages (from-to)751-755
Number of pages5
JournalJournal of Reproductive Medicine for the Obstetrician and Gynecologist
Volume48
Issue number10
StatePublished - Oct 2003

Fingerprint

Conization
Papanicolaou Test
Fertility
Safety Management
Curettage
Lost to Follow-Up
Biopsy
Adenocarcinoma in Situ
Conservative Treatment

Keywords

  • Adenocarcinoma
  • Cervical cancer
  • Post-conization surveillance

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Reproductive Medicine

Cite this

Postconization Surveillance of Cervical Adenocarcinoma in Situ : A Prospective Trial. / Schorge, John O.; Lea, Jayanthi S.; Ashfaq, Raheela.

In: Journal of Reproductive Medicine for the Obstetrician and Gynecologist, Vol. 48, No. 10, 10.2003, p. 751-755.

Research output: Contribution to journalArticle

@article{3038c5a7b884476ab22ba87f6e62ebf7,
title = "Postconization Surveillance of Cervical Adenocarcinoma in Situ: A Prospective Trial",
abstract = "OBJECTIVE: To conduct a surveillance trial after conization to prospectively determine the outcome of conservative management of adenocarcinoma in situ (AIS). STUDY DESIGN: Women diagnosed with AIS were prospectively enrolled from September 2000 to September 2001. Eligibility criteria included patient age younger than 40 years, prior conization with negative margins and the desire to preserve fertility. Each cone biopsy specimen was secondarily reviewed. Postconization surveillance consisted of a liquid-based Pap test and endocervical curettage (ECC) every 4 months. Follow-up ended in September 2002. RESULTS: Ten women with a median age of 32 years (range, 26-37) were enrolled. Six were nulliparous and 2 primiparous. Seven patients were clinically free of disease after a median of 21 months (range, 5-24), 2 were lost to follow-up, and 1 was excluded when AIS could not be confirmed on the original specimen. Twenty-eight Pap smears and 18 ECCs were performed, but no additional surgical procedures were required due to abnormal cytopathology. CONCLUSION: This prospective trial on postconization surveillance demonstrated the safety of conservative management for AIS patients desiring to preserve fertility.",
keywords = "Adenocarcinoma, Cervical cancer, Post-conization surveillance",
author = "Schorge, {John O.} and Lea, {Jayanthi S.} and Raheela Ashfaq",
year = "2003",
month = "10",
language = "English (US)",
volume = "48",
pages = "751--755",
journal = "The Journal of reproductive medicine",
issn = "0024-7758",
publisher = "Donna Kessel",
number = "10",

}

TY - JOUR

T1 - Postconization Surveillance of Cervical Adenocarcinoma in Situ

T2 - A Prospective Trial

AU - Schorge, John O.

AU - Lea, Jayanthi S.

AU - Ashfaq, Raheela

PY - 2003/10

Y1 - 2003/10

N2 - OBJECTIVE: To conduct a surveillance trial after conization to prospectively determine the outcome of conservative management of adenocarcinoma in situ (AIS). STUDY DESIGN: Women diagnosed with AIS were prospectively enrolled from September 2000 to September 2001. Eligibility criteria included patient age younger than 40 years, prior conization with negative margins and the desire to preserve fertility. Each cone biopsy specimen was secondarily reviewed. Postconization surveillance consisted of a liquid-based Pap test and endocervical curettage (ECC) every 4 months. Follow-up ended in September 2002. RESULTS: Ten women with a median age of 32 years (range, 26-37) were enrolled. Six were nulliparous and 2 primiparous. Seven patients were clinically free of disease after a median of 21 months (range, 5-24), 2 were lost to follow-up, and 1 was excluded when AIS could not be confirmed on the original specimen. Twenty-eight Pap smears and 18 ECCs were performed, but no additional surgical procedures were required due to abnormal cytopathology. CONCLUSION: This prospective trial on postconization surveillance demonstrated the safety of conservative management for AIS patients desiring to preserve fertility.

AB - OBJECTIVE: To conduct a surveillance trial after conization to prospectively determine the outcome of conservative management of adenocarcinoma in situ (AIS). STUDY DESIGN: Women diagnosed with AIS were prospectively enrolled from September 2000 to September 2001. Eligibility criteria included patient age younger than 40 years, prior conization with negative margins and the desire to preserve fertility. Each cone biopsy specimen was secondarily reviewed. Postconization surveillance consisted of a liquid-based Pap test and endocervical curettage (ECC) every 4 months. Follow-up ended in September 2002. RESULTS: Ten women with a median age of 32 years (range, 26-37) were enrolled. Six were nulliparous and 2 primiparous. Seven patients were clinically free of disease after a median of 21 months (range, 5-24), 2 were lost to follow-up, and 1 was excluded when AIS could not be confirmed on the original specimen. Twenty-eight Pap smears and 18 ECCs were performed, but no additional surgical procedures were required due to abnormal cytopathology. CONCLUSION: This prospective trial on postconization surveillance demonstrated the safety of conservative management for AIS patients desiring to preserve fertility.

KW - Adenocarcinoma

KW - Cervical cancer

KW - Post-conization surveillance

UR - http://www.scopus.com/inward/record.url?scp=0142182626&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0142182626&partnerID=8YFLogxK

M3 - Article

C2 - 14619639

AN - SCOPUS:0142182626

VL - 48

SP - 751

EP - 755

JO - The Journal of reproductive medicine

JF - The Journal of reproductive medicine

SN - 0024-7758

IS - 10

ER -